Sumitomo Chemical India Ltd (SUMICHEM)

📊 Quarterly Results (₹ Cr)

The company's financial trajectory shows a clear inflection toward higher profitability and operational efficiency, despite flat revenue growth in Q1 FY27. Net profit rose 20% YoY to ₹215 crores with margins expanding significantly — net profit margin up 332 bps to 20.2% and EBITDA margin up 120 bps to 21.9% — driven by cost optimization and insurance recoveries. Sequential performance indicates improvement: OPM rose to 20.3% in Jun 2026 from 14.6% in Dec 2025, and net profit grew from ₹76 crores (Dec 2025) to ₹215 crores (Jun 2026). This upward trend aligns with management’s focus on margin enhancement and strategic CAPEX, signaling effective execution amid monsoon volatility and sectoral challenges.

🔮 Management Outlook & What's Next

Management expressed confidence in sustained momentum, citing operational resilience and strategic CAPEX as catalysts for future growth. They highlighted the Tarapur and Dahej plant expansions targeting commercialization by Q4 FY27 and Q2 FY28 respectively, which are central to their medium-term growth strategy. Despite monsoon-related volume pressures, management emphasized the business’s resilience and effective cash management, with ₹2,549 crores in cash supporting working capital and CAPEX. No specific revenue or margin guidance was provided beyond operational milestones, but the focus remains on scaling high-margin products and improving asset utilization.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

The balance sheet reflects a strong and stable financial foundation, with equity held steady at ₹499 crores and reserves growing to ₹2,891 crores as of Mar 2026, indicating healthy retained earnings. Borrowings remain minimal at ₹58 crores, down from ₹52 crores a year ago, underscoring a conservative capital structure. Total assets have risen to ₹4,474 crores, driven by operational scale and investments. Management is deploying cash strategically through CAPEX while maintaining ample liquidity, suggesting a balanced approach to growth and financial discipline without over-leveraging the company.

💰 Cash Flow Statement (₹ Cr)

👥 Shareholding Pattern

Shareholding patterns show stable promoter holding at 75% over the past year, with a slight decline in FII ownership from 3.65% (Q2 FY26) to 3.02% (Q1 FY27), while DII increased from 8.47% to 9.33%. Public shareholding rose to 9.12% in Q1 FY27 from 9.8% in Q3 FY26, though the number of shareholders has grown to 1,10,464. There are no signs of significant institutional exit or dilution, and the rising DII stake suggests growing institutional confidence. No pledging or selling by promoters is indicated, and the increasing shareholder base may reflect retail interest following dividend declarations and operational improvements.

⚖️ Peer Comparison — Agro Chemicals

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. Monsoon dependency remains a structural risk, as evidenced by 20% lower kharif sowing and 40% rainfall deficit in FY27, which could impact volume growth despite current resilience. 2. Ongoing regulatory scrutiny over glyphosate usage poses potential compliance and market access risks, as highlighted in board discussions. 3. Integration and execution risks are associated with the ₹160 crores CAPEX for Tarapur and herbicide expansions, with timelines extending to FY28. 4. Volatility from exceptional items, such as insurance recoveries, may affect future earnings comparability if not recurring.

📋 Recent Filings

• 🟡 Board Meeting2026-10-01The board of Sumitomo Chemical India Ltd announced a meeting scheduled for 26 October 2026 to review standalone and consolidated unaudited financial r…
• Announcement2026-08-25Sumitomo Chemical India announced a schedule of investor and analyst meetings starting September 3, 2026, including one-on-one and group sessions with…
• Announcement2026-08-10Sumitomo Chemical India announced a scheduled group meeting with Motilal Oswal Financial Services on August 19, 2026 at 3:00 pm in Mumbai to discuss p…
• 🟡 Board Meeting2026-07-27The Board of Sumitomo Chemical India Limited approved unaudited standalone and consolidated financial results for the quarter ended 30 June 2026 durin…
• 🟡 Board Meeting2026-07-27Sumitomo Chemical India announced the resignation of Non-Executive Director Ninad D. Gupte effective 31 August 2026, citing personal reasons. The fili…
• 🔴 Financial Results2026-07-27Sumitomo Chemical India reported standalone revenue of **₹11,011.38 crores** for Q1 FY2026, up 69.9% YoY from ₹6,500 crores, driven by a 69.9% surge i…
• 🟡 Board Meeting2026-07-27Sumitomo Chemical India held its 26th Annual General Meeting on 27 July 2026 via video conference, adopting audited financial statements for FY2025-26…
• 🔴 Financial Results2026-07-27Sumitomo Chemical India reported Q1FY27 revenue of **₹1,063.3 crores**, up 1% YoY, with net profit surging 20% to **₹215 crores** and EBITDA rising 6%…
• 🔴 Insider Trading2026-07-14Sumitomo Chemical India Limited confirmed compliance with SEBI's dematerialisation regulations for the quarter ended June 30, 2026, via a certificate …
• 🟡 Board Meeting2026-07-02The 26th Annual General Meeting of Sumitomo Chemical India Limited will be held on 27 July 2026 at 2:30 PM IST via Video Conferencing. Shareholders wi…

🧠 Analyst's Read

Sumitomo Chemical India is navigating a challenging macro environment with operational discipline and strategic investments, as evidenced by margin expansion and cash-driven growth. Investors should monitor the progress of CAPEX milestones and the impact of monsoon dynamics on kharif demand, while remaining cautious of regulatory headwinds. The company’s resilience and governance stability support a neutral long-term stance, but near-term execution will be critical.

Based on filing content and financial data. Not a recommendation.